18F-FDG-PET, gallium-67 and somatostatin receptor scintigraphy, in ocular MALT lymphoma

Hellenic Journal of Nuclear Medicine

Volumn 11, Issue 1, 2008, Pages 49-

  Dabbagh Kakhki, Vahid Reza ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GALLIUM CITRATE GA 67; CITRIC ACID; DIAGNOSTIC AGENT; GALLIUM; GALLIUM CITRATE; RADIOPHARMACEUTICAL AGENT;

COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG SPECIFICITY; DRUG UPTAKE; EYE CANCER; EYE EXAMINATION; FALSE NEGATIVE RESULT; HUMAN; INTERMETHOD COMPARISON; LETTER; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NONHODGKIN LYMPHOMA; POSITRON EMISSION TOMOGRAPHY; SCINTIGRAPHY; SENSITIVITY AND SPECIFICITY; SOMATOSTATIN RECEPTOR SCINTIGRAPHY; STOMACH LYMPHOMA; AGED; AUTOPSY; CANCER STAGING; CONJUNCTIVA TUMOR; CORNEA DISEASE; EYE TUMOR; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; RADIOGRAPHY;

AGED; AGED, 80 AND OVER; AUTOPSY; CITRATES; CONJUNCTIVAL NEOPLASMS; CORNEAL DISEASES; EYE NEOPLASMS; GALLIUM; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOMA, B-CELL, MARGINAL ZONE; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEOPLASM STAGING; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 43249105799     PISSN: 11081430     EISSN: 17905427     Source Type: Journal    
DOI: None     Document Type: Letter

References (14)

1. Yaylali OT, Kirac FS, Yaylali V et al. Gallium-67 citrate scintigraphy and marginal zone of mucosa-associated lymphoid tissue. Ocular MALT. Hell J Nucl Med 2007; 10: 160-163.
2. Even-Sapir E, Israel O. Gallium-67 scintigraphy: a cornerstone in functional imaging of lymphoma. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl. 1): S65-S81.
3. Khoury J, Nassrala S, Loberant N, Jerushalmi J. Gamut: Unilateral orbital uptake on Ga-67 scintigraphy. Sem Nucl Med 2003; 33:331-333.
4. Perry C, Herishanu Y, Metzer U et al. Diagnostic accuracy of PET/CT in patients with extranodal marginal zone MALT lymphoma. Eur J Haematol 2007; 79: 205-209.
5. Beal KP, Yeung HW, Yaholam J. FDG-PET scanning or detection and staging of extranodal marginal zone lymphomas of the MALT type: a report of 42 cases. Ann Oncol 2005; 16: 473-480.
6. Hoffmann M, Kletter K, Diemling M et al. Positron emission tomography with fluorine-18-2-fluoro-2-deoxy-D-glucose (F18-FDG) does not visualize extranodal B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT)-type. Ann Oncol 1999; 10: 1185-1189.
7. 18F-Fluoro-deoxy-glucose positron emission tomography (18F-FDG-PET) for staging and follow-up of marginal zone B-cell lymphoma. Oncology 2003; 64: 336-340.
8. 18F-Fluoro-deoxy-glucose positron emission tomography in lymphoma of mucosa-associated lymphoid tissue: histology makes the difference. Ann Oncol 2006; 17: 1761-1765.
9. Alinari L, Castellucci P, Elstrom R et al. FDG PET in mucosa-associated lymphoid tissue (MALT) lymphoma. Leuk Lymphoma 2006; 47: 2096-2101.
10. Elstrom R, Guan L, Baker G et al. Utility of FDG-PET scanning in lymphoma by WHO classification. Blood 2003; 101: 3875-3876.
11. Lugtenburg PJ, Löwenberg B, Valkema R et al. Somatostatin receptor scintigraphy in the initial staging of low-grade non-Hodgkin's lymphomas. J Nucl Med 2001; 42: 222-229.
12. 67Ga citrate scintigraphy for visualisation of extranodal marginal zone B-cell lymphoma of the MALT type: a comparative study. Eur J Nucl Med Mol Imaging 2003; 30: 1087-1095.
13. Raderer M, Valecak J, Pfeffel F et al. Somatostatin receptor expression in primary gastric versus nongastric extranodal B-cell lymphoma of mucosa-associated lymphoid tissue type. J Natl Cancer Inst 1999; 91:716-718.
14. Ferone D, Sernino C, Boschetti M et al. Initial staging of lymphoma with octreotide and other receptor imaging agents. Semin Nucl Med 2005; 35: 176-185.